Madrigal Pharmaceuticals (MDGL) Stock Price

$269.9 0.3%

Sign up
to add to portfolio

AI Score

Buy

  • Alternative

    9

  • Fundamental

    7

  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Madrigal Pharmaceuticals, AI stock picks, stock alerts and much more.

Sign up

MDGL AI Stock Analysis

AI stock analysis for MDGL is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Madrigal Pharmaceuticals (MDGL) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Madrigal Pharmaceuticals (MDGL) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Madrigal Pharmaceuticals (MDGL), currently trading at $269.9, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About MDGL

LSE

  • Madrigal Pharmaceuticals, Inc.

  • Symbol

    MDGL

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    6B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $24.58
0.2%
7
INO Inovio Pharmaceuticals
INO		 $2.13
6.5%
2
MRNA Moderna
MRNA		 $26.93
3.4%
3
AVXL Anavex Life Sciences
AVXL		 $7.63
0.7%
6
BBIO BridgeBio Pharma
BBIO		 $33.37
3.4%
7

News

In Search Of A Tailwind, Sailing The Doldrums With Madrigal Pharmaceuticals

In Search Of A Tailwind, Sailing The Doldrums With Madrigal Pharmaceuticals
May 17, 2025. seekingalpha.com
Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis

Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis
May 10, 2025. globenewswire.com
Madrigal Pharmaceuticals: An Encouraging Start For Rezdiffra

Madrigal Pharmaceuticals: An Encouraging Start For Rezdiffra
May 6, 2025. seekingalpha.com
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2025 Earnings Call Transcript

Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2025 Earnings Call Transcript
May 1, 2025. seekingalpha.com

MDGL Alternative Data

Web Traffic

Madrigal Pharmaceuticals receives an estimated 25399 monthly visitors to madrigalpharma.com.

  • Web Traffic

    25399

  • Change from Previous Month

    7.9%

  • 3 Month Change

    19.5%

  • YoY Change

    19.5%

Twitter Followers

Madrigal Pharmaceuticals has 1,515 Twitter Followers on its main Twitter (also known as X) account, which is up by 1.1% over the last month.

  • Twitter Followers

    1515

  • Daily Change

    0.1%

  • 1 Month Change

    1.1%

  • 3 Month Change

    2%

  • YoY Change

    2%

Facebook Engagement

Madrigal Pharmaceuticals has engaged 0 users via their Facebook Page over the last 7 days.

  • Facebook Engagement

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Followers

59,575 are following Madrigal Pharmaceuticals on LinkedIn, up by 3.2% over the last month.

  • LinkedIn Followers

    59575

  • Daily Change

    0.1%

  • 1 Month Change

    3.2%

  • 3 Month Change

    9.8%

Job Postings

Madrigal Pharmaceuticals has an estimated 28 open job postings, which is down -50% over the last month.

  • Job Postings

    28

  • Daily Change

    3.4%

  • 1 Month Change

    50%

  • 3 Month Change

    56.9%

  • YoY Change

    56.9%

LinkedIn Employees

According to LinkedIn, Madrigal Pharmaceuticals has 694 employees, up by 5.3% over the last month.

  • LinkedIn Employees

    694

  • Daily Change

    0%

  • 1 Month Change

    5.3%

  • 3 Month Change

    17.6%

  • YoY Change

    17.6%

Reddit Mentions

Madrigal Pharmaceuticals has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Business Outlook

According to employee reviews, the business outlook among employees at Madrigal Pharmaceuticals is 100 out of 100 (very bullish).

  • Business Outlook

    100

  • Change from Previous Month

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

News Mentions

Madrigal Pharmaceuticals was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    100%

  • 1 Month Change

    0%

  • 3 Month Change

    100%

Youtube Subscribers

Madrigal Pharmaceuticals has 116 subscribers on its main Youtube channel.

  • Youtube Subscribers

    116

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

MDGL Financials

MDGL Key Metrics

  • Total Revenue

    $137.3M

  • Net Income

    -$73.2M

  • Earnings per Share

    -$3.32

  • Free cash flow

    -$88.9M

  • EBITDA

    -$69.6M

  • EBITDA Ratio

    -0.506827

  • Total Assets

    $996.6M

MDGL 2-year Revenue & Income
MDGL 2-year Free Cash Flow

MDGL Technicals

MDGL SMA
MDGL RSI

FAQ

What's the current price of Madrigal Pharmaceuticals (MDGL) Stock?
The price of an Madrigal Pharmaceuticals (MDGL) share is $269.9.

What's the market cap of Madrigal Pharmaceuticals?
The current market cap of Madrigal Pharmaceuticals is 6B.

Should I buy or sell MDGL?
Multiple alternative data signals suggest that Madrigal Pharmaceuticals stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.

Is Madrigal Pharmaceuticals a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Madrigal Pharmaceuticals stock. The bullish indicators suggest that Madrigal Pharmaceuticals' growth prospects and market position may lead to a positive performance in the foreseeable future.

Is now a good time to buy Madrigal Pharmaceuticals (MDGL) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Madrigal Pharmaceuticals stock, given the bullish outlook.

What are some stocks similar to Madrigal Pharmaceuticals (MDGL) that investors often compare it to?
Madrigal Pharmaceuticals (MDGL) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Madrigal Pharmaceuticals' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Madrigal Pharmaceuticals' stock price to be around $300.5 in 2026. Starting from the current price of $269.9, this represents a 11.3% change in price, indicating a bullish outlook for the stock.

How to buy Madrigal Pharmaceuticals (MDGL) Stock?
Madrigal Pharmaceuticals stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Madrigal Pharmaceuticals shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.